Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICESAMS · Entity 8010 | Director | June 18, 2019 | June 21, 2019 |
| Forian Inc.FORA · Entity 47119 | Director | March 26, 2025 | March 28, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMERICAN SHARED HOSPITAL SERVICES
Report date June 18, 2019 · Filed June 21, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, No Par ValueSEC Table I · non-derivative | Direct | 87,847 |
Ending reported balance
After 2019-06-18 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2019-06-18 · Exercise / conversion · Acquired 2,000 · Balance 81,847 Row 2 · 2019-06-18 · Exercise / conversion · Acquired 2,000 · Balance 83,847 Row 3 · 2019-06-18 · Exercise / conversion · Acquired 2,000 · Balance 85,847 Row 4 · 2019-06-18 · Exercise / conversion · Acquired 2,000 · Balance 87,847 |
| Stock optionsSEC Table II · derivative / convertible security · Conversion / exercise price $2.16 · Expires 2020-06-10 | Direct | 0 |
Reported balance
After 2019-06-18 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2019-06-18 · Exercise / conversion · Disposed 2,000 · Balance 0 |
| Stock optionsSEC Table II · derivative / convertible security · Conversion / exercise price $2.43 · Expires 2021-06-09 | Direct | 0 |
Reported balance
After 2019-06-18 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2019-06-18 · Exercise / conversion · Disposed 2,000 · Balance 0 |
| Stock optionsSEC Table II · derivative / convertible security · Conversion / exercise price $2.25 · Expires 2023-06-20 | Direct | 0 |
Reported balance
After 2019-06-18 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2019-06-18 · Exercise / conversion · Disposed 2,000 · Balance 0 |
| Stock optionsSEC Table II · derivative / convertible security · Conversion / exercise price $2.68 · Expires 2025-06-13 | Direct | 0 |
Reported balance
After 2019-06-18 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2019-06-18 · Exercise / conversion · Disposed 2,000 · Balance 0 |
Forian Inc.
Report date March 26, 2025 · Filed March 28, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.06 · Expires 2035-03-26 | Direct | 15,000 |
Reported balance
After 2025-03-26 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-03-26 · Grant · Acquired 15,000 · Balance 15,000 F1: The stock option vests in four equal annual installments beginning on March 26, 2026, subject to the Reporting Person's continued service as a non-employee director of the Issuer on each applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock option vests in four equal annual installments beginning on March 26, 2026, subject to the Reporting Person's continued service as a non-employee director of the Issuer on each applicable vesting date.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
WebMD Health Corp.
Report date September 15, 2017 · Filed September 15, 2017
Section 16 reporting ended · disclosed 2017-09-15. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-09-15 transaction · row 1
1 source rowRow 1 · 2017-09-15 · Other · Disposed 20,689 · Balance 0 F1: Sold in a tender offer made by Diagnosis Merger Sub, Inc., a Delaware Corporation ("Purchaser") and a wholly-owned subsidiary of MH Sub I, LLC, a Delaware limited liability company ("Parent"), to purchase all of the issued and outstanding shares of common stock of WebMD Health Corp., a Delaware corporation ("WebMD"), for $66.50 per share, pursuant to the terms of that certain Agreement and Plan of Merger, dated as of July 24, 2017, by and among WebMD, Purchaser, and Parent (the "Merger Agreement"). |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 0 |
Reported balance
After 2017-09-15 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2017-09-15 · Other · Disposed 935 · Balance 0 F1: Sold in a tender offer made by Diagnosis Merger Sub, Inc., a Delaware Corporation ("Purchaser") and a wholly-owned subsidiary of MH Sub I, LLC, a Delaware limited liability company ("Parent"), to purchase all of the issued and outstanding shares of common stock of WebMD Health Corp., a Delaware corporation ("WebMD"), for $66.50 per share, pursuant to the terms of that certain Agreement and Plan of Merger, dated as of July 24, 2017, by and among WebMD, Purchaser, and Parent (the "Merger Agreement"). |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $38.49 · Expires 2020-01-01 | Direct | 0 |
Reported balance
After 2017-09-15 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2017-09-15 · Disposition to issuer · Disposed 13,200 · Balance 0 F2: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $37.55 · Expires 2022-01-01 | Direct | 0 |
Reported balance
After 2017-09-15 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2017-09-15 · Disposition to issuer · Disposed 13,200 · Balance 0 F2: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $14.34 · Expires 2023-01-01 | Direct | 0 |
Reported balance
After 2017-09-15 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2017-09-15 · Disposition to issuer · Disposed 6,600 · Balance 0 F2: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $39.50 · Expires 2024-01-01 | Direct | 0 |
Reported balance
After 2017-09-15 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2017-09-15 · Disposition to issuer · Disposed 13,200 · Balance 0 F2: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $39.55 · Expires 2025-01-01 | Direct | 0 |
Reported balance
After 2017-09-15 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2017-09-15 · Disposition to issuer · Disposed 13,200 · Balance 0 F2: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $48.30 · Expires 2026-01-01 | Direct | 0 |
Reported balance
After 2017-09-15 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2017-09-15 · Disposition to issuer · Disposed 13,200 · Balance 0 F2: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $49.57 · Expires 2027-01-01 | Direct | 0 |
Reported balance
After 2017-09-15 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2017-09-15 · Disposition to issuer · Disposed 13,200 · Balance 0 F2: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD. |
Filing footnotes · ownership attribution and instrument terms
F1: Sold in a tender offer made by Diagnosis Merger Sub, Inc., a Delaware Corporation ("Purchaser") and a wholly-owned subsidiary of MH Sub I, LLC, a Delaware limited liability company ("Parent"), to purchase all of the issued and outstanding shares of common stock of WebMD Health Corp., a Delaware corporation ("WebMD"), for $66.50 per share, pursuant to the terms of that certain Agreement and Plan of Merger, dated as of July 24, 2017, by and among WebMD, Purchaser, and Parent (the "Merger Agreement").
F2: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 26, 2025 Filed Mar 28, 2025 22:55 UTC | Forian Inc. FORA · Entity 47119 | GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $2.06 | $0.00 |
DisclosureSEC source: 0001140361-25-011041 · form4.xml · derivative · entry 1 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2035-03-26 F1 · derivative.exercise_date: The stock option vests in four equal annual installments beginning on March 26, 2026, subject to the Reporting Person's continued service as a non-employee director of the Issuer on each applicable vesting date. Read SEC document |
| March 27, 2024 Filed Mar 28, 2024 23:39 UTC | Forian Inc. FORA · Entity 47119 | GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $3.20 | $0.00 |
DisclosureSEC source: 0001140361-24-016321 · form4.xml · derivative · entry 1 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2034-03-27 F1 · derivative.exercise_date: The stock option vests in four equal annual installments beginning on March 27, 2025, subject to the Reporting Person's continued service as a non-employee director of the Issuer on each applicable vesting date. Read SEC document |
| May 17, 2023 Filed May 18, 2023 20:32 UTC | Forian Inc. FORA · Entity 47119 | PurchaseCommon Stock | 12,343 | $2.40 | $29,623.20 |
DisclosureSEC source: 0001140361-23-025491 · form4.xml · nonDerivative · entry 2 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · The Stanley Trotman Jr. Revocable Trust Disclosed balance after: 147,500 F2 · price: The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $2.39 to $2.43, inclusive. Upon request of the SEC staff or the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| May 16, 2023 Filed May 18, 2023 20:32 UTC | Forian Inc. FORA · Entity 47119 | PurchaseCommon Stock | 7,657 | $2.40 | $18,376.80 |
DisclosureSEC source: 0001140361-23-025491 · form4.xml · nonDerivative · entry 1 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · The Stanley Trotman Jr. Revocable Trust Disclosed balance after: 135,157 F1 · price: The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $2.36 to $2.40, inclusive. Upon request of the SEC staff or the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| March 23, 2023 Filed Mar 24, 2023 22:50 UTC | Forian Inc. FORA · Entity 47119 | GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $3.14 | $0.00 |
DisclosureSEC source: 0001140361-23-013812 · form4.xml · derivative · entry 1 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2033-03-23 F1 · derivative.exercise_date: The stock option vests in four equal annual installments beginning on March 23, 2024, subject to the Reporting Person's continued service as a non-employee director of the Issuer on each applicable vesting date. Read SEC document |
| March 29, 2022 Filed Mar 31, 2022 23:18 UTC | Forian Inc. FORA · Entity 47119 | PurchaseCommon Stock | 10,000 | $6.45 | $64,500.00 |
DisclosureSEC source: 0001140361-22-012391 · form4.xml · nonDerivative · entry 1 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · The Stanley Trotman Jr. Revocable Trust Disclosed balance after: 127,500 F1 · price: The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $6.34 to $6.51, inclusive. Upon request of the SEC staff or the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| March 17, 2022 Filed Apr 18, 2022 23:54 UTC | Forian Inc. FORA · Entity 47119 | GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $6.81 | $0.00 |
DisclosureSEC source: 0001140361-22-014921 · form4.xml · derivative · entry 1 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2032-03-17 F1 · derivative.exercise_date: The stock option vests in four equal annual installments beginning on March 17, 2023, subject to the Reporting Person's continued service as a non-employee director of the Issuer on each applicable vesting date. Read SEC document |
| January 07, 2022 Filed Jan 8, 2022 00:18 UTC | Forian Inc. FORA · Entity 47119 | PurchaseCommon Stock | 2,500 | $7.91 | $19,775.00 |
DisclosureSEC source: 0001140361-22-000999 · form4.xml · nonDerivative · entry 2 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · The Stanley Trotman Jr. Revocable Trust Disclosed balance after: 117,500 F2 · price: The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $7.84 to $7.94, inclusive. Upon request of the SEC staff or the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| January 05, 2022 Filed Jan 8, 2022 00:18 UTC | Forian Inc. FORA · Entity 47119 | PurchaseCommon Stock | 5,000 | $8.04 | $40,200.00 |
DisclosureSEC source: 0001140361-22-000999 · form4.xml · nonDerivative · entry 1 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · The Stanley Trotman Jr. Revocable Trust Disclosed balance after: 115,000 F1 · price: The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $7.19 to $8.19, inclusive. Upon request of the SEC staff or the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| December 22, 2021 Filed Dec 24, 2021 00:05 UTC | Forian Inc. FORA · Entity 47119 | PurchaseCommon Stock | 7,524 | $8.56 | $64,405.44 |
DisclosureSEC source: 0001140361-21-042983 · form4.xml · nonDerivative · entry 1 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · The Stanley Trotman Jr. Revocable Trust Disclosed balance after: 110,000 F1 · price: The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $8.45 to $8.66, inclusive. Upon request of the SEC staff or the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| December 21, 2021 Filed Dec 22, 2021 02:16 UTC | Forian Inc. FORA · Entity 47119 | PurchaseCommon Stock | 5,159 | $8.64 | $44,573.76 |
DisclosureSEC source: 0001140361-21-042661 · form4.xml · nonDerivative · entry 4 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · The Stanley Trotman Jr. Revocable Trust Disclosed balance after: 102,476 F4 · price: The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $8.45 to $8.69, inclusive. Upon request of the SEC staff or the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| December 20, 2021 Filed Dec 22, 2021 02:16 UTC | Forian Inc. FORA · Entity 47119 | PurchaseCommon Stock | 10,000 | $8.68 | $86,800.00 |
DisclosureSEC source: 0001140361-21-042661 · form4.xml · nonDerivative · entry 3 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · The Stanley Trotman Jr. Revocable Trust Disclosed balance after: 97,317 F3 · price: The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $8.39 to $8.70, inclusive. Upon request of the SEC staff or the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| December 20, 2021 Filed Dec 22, 2021 02:16 UTC | Forian Inc. FORA · Entity 47119 | GiftCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-21-042661 · form4.xml · nonDerivative · entry 2 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · The Stanley Trotman Gifting Trust Disclosed balance after: 87,317 F2 · balance_after: On December 20, 2021, the reporting person gifted 25,000 shares to one of his children who is a beneficiary of the Stanley Trotman Gifting Trust. Read SEC document |
| December 17, 2021 Filed Dec 22, 2021 02:16 UTC | Forian Inc. FORA · Entity 47119 | PurchaseCommon Stock | 2,473 | $8.25 | $20,402.25 |
DisclosureSEC source: 0001140361-21-042661 · form4.xml · nonDerivative · entry 1 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · The Stanley Trotman Jr. Revocable Trust Disclosed balance after: 112,317 F1 · price: The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $8.15 to $8.35, inclusive. Upon request of the SEC staff or the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| April 12, 2021 Filed Apr 15, 2021 01:24 UTC | Forian Inc. FORA · Entity 47119 | GrantCommon Stock | 50,000 | $11.33 | $566,500.00 |
DisclosureSEC source: 0001140361-21-012835 · form4.xml · nonDerivative · entry 1 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,844 F1 · shares: The reporting person purchased the shares pursuant to that certain Securities Purchase Agreement, dated April 12, 2021, by and among the issuer, the reporting person and the other investors thereto. Read SEC document |
| March 19, 2021 Filed Mar 23, 2021 01:13 UTC | Forian Inc. FORA · Entity 47119 | PurchaseCommon Stock | 2,612 | $12.63 | $32,983.81 |
DisclosureSEC source: 0001140361-21-009516 · form4.xml · nonDerivative · entry 2 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,844 F2 · price: The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $12.52 to $12.70, inclusive. Upon request of the SEC staff or the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| March 18, 2021 Filed Mar 23, 2021 01:13 UTC | Forian Inc. FORA · Entity 47119 | PurchaseCommon Stock | 1,475 | $12.27 | $18,093.97 |
DisclosureSEC source: 0001140361-21-009516 · form4.xml · nonDerivative · entry 1 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,232 F1 · price: The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $12.13 to $12.37, inclusive. Upon request of the SEC staff or the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| March 17, 2021 Filed Mar 17, 2021 23:35 UTC | Forian Inc. FORA · Entity 47119 | PurchaseCommon Stock | 3,057 | $12.31 | $37,627.39 |
DisclosureSEC source: 0001140361-21-008946 · form4.xml · nonDerivative · entry 3 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,757 F3 · price: The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $12.14 to $12.50, inclusive. Upon request of the SEC staff or the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| March 16, 2021 Filed Mar 17, 2021 23:35 UTC | Forian Inc. FORA · Entity 47119 | PurchaseCommon Stock | 4,067 | $12.21 | $49,668.24 |
DisclosureSEC source: 0001140361-21-008946 · form4.xml · nonDerivative · entry 2 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,700 F2 · price: The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $12.00 to $12.40, inclusive. Upon request of the SEC staff or the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 23:35 UTC | Forian Inc. FORA · Entity 47119 | PurchaseCommon Stock | 4,333 | $12.42 | $53,798.96 |
DisclosureSEC source: 0001140361-21-008946 · form4.xml · nonDerivative · entry 1 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,633 F1 · price: The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $12.24 to $12.65, inclusive. Upon request of the SEC staff or the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| March 12, 2021 Filed Mar 13, 2021 01:13 UTC | Forian Inc. FORA · Entity 47119 | PurchaseCommon Stock | 7,202 | $12.32 | $88,694.07 |
DisclosureSEC source: 0001140361-21-008398 · form4.xml · nonDerivative · entry 3 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,300 F2 · price: The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $12.12 to $12.45, inclusive. Upon request of the SEC staff or the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| March 11, 2021 Filed Mar 13, 2021 01:13 UTC | Forian Inc. FORA · Entity 47119 | PurchaseCommon Stock | 100 | $12.12 | $1,212.00 |
DisclosureSEC source: 0001140361-21-008398 · form4.xml · nonDerivative · entry 2 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,098 Read SEC document |
| March 10, 2021 Filed Mar 13, 2021 01:13 UTC | Forian Inc. FORA · Entity 47119 | PurchaseCommon Stock | 13,241 | $11.93 | $157,970.43 |
DisclosureSEC source: 0001140361-21-008398 · form4.xml · nonDerivative · entry 1 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,998 F1 · price: The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $11.77 to $11.95, inclusive. Upon request of the SEC staff or the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 22:28 UTC | Forian Inc. FORA · Entity 47119 | GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $12.18 | $0.00 |
DisclosureSEC source: 0001140361-21-007813 · form4.xml · derivative · entry 2 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2031-03-05 F2 · derivative.exercise_date: The stock option vests in four equal annual installments beginning on March 2, 2022, subject to the Reporting Person's continued service as a non-employee director of the Issuer on each applicable vesting date. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 22:28 UTC | Forian Inc. FORA · Entity 47119 | GrantRestricted Stock Units | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-21-007813 · form4.xml · nonDerivative · entry 1 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 F1 · shares: Represents 5,000 restricted stock units which vest in four equal annual installments beginning on March 2, 2022, subject to the Reporting Person's continued service as a non-employee director of the Issuer on each applicable vesting date. Read SEC document |
| June 18, 2019 Filed Jun 21, 2019 00:05 UTC | AMERICAN SHARED HOSPITAL SERVICES AMS · Entity 8010 | Exercise / conversionStock options · Derivative | 2,000 | $0.00 Strike: $2.68 | $0.00 |
DisclosureSEC source: 0000950103-19-008240 · dp108648_4-trotman.xml · derivative · entry 8 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 2,000 shares Expires 2025-06-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 18, 2019 Filed Jun 21, 2019 00:05 UTC | AMERICAN SHARED HOSPITAL SERVICES AMS · Entity 8010 | Exercise / conversionStock options · Derivative | 2,000 | $0.00 Strike: $2.25 | $0.00 |
DisclosureSEC source: 0000950103-19-008240 · dp108648_4-trotman.xml · derivative · entry 7 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 2,000 shares Expires 2023-06-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 18, 2019 Filed Jun 21, 2019 00:05 UTC | AMERICAN SHARED HOSPITAL SERVICES AMS · Entity 8010 | Exercise / conversionStock options · Derivative | 2,000 | $0.00 Strike: $2.43 | $0.00 |
DisclosureSEC source: 0000950103-19-008240 · dp108648_4-trotman.xml · derivative · entry 6 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 2,000 shares Expires 2021-06-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 18, 2019 Filed Jun 21, 2019 00:05 UTC | AMERICAN SHARED HOSPITAL SERVICES AMS · Entity 8010 | Exercise / conversionStock options · Derivative | 2,000 | $0.00 Strike: $2.16 | $0.00 |
DisclosureSEC source: 0000950103-19-008240 · dp108648_4-trotman.xml · derivative · entry 5 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 2,000 shares Expires 2020-06-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 18, 2019 Filed Jun 21, 2019 00:05 UTC | AMERICAN SHARED HOSPITAL SERVICES AMS · Entity 8010 | Exercise / conversionCommon Stock, No Par Value | 2,000 | $2.68 | $5,360.00 |
DisclosureSEC source: 0000950103-19-008240 · dp108648_4-trotman.xml · nonDerivative · entry 4 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,847 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 18, 2019 Filed Jun 21, 2019 00:05 UTC | AMERICAN SHARED HOSPITAL SERVICES AMS · Entity 8010 | Exercise / conversionCommon Stock, No Par Value | 2,000 | $2.25 | $4,500.00 |
DisclosureSEC source: 0000950103-19-008240 · dp108648_4-trotman.xml · nonDerivative · entry 3 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,847 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 18, 2019 Filed Jun 21, 2019 00:05 UTC | AMERICAN SHARED HOSPITAL SERVICES AMS · Entity 8010 | Exercise / conversionCommon Stock, No Par Value | 2,000 | $2.43 | $4,860.00 |
DisclosureSEC source: 0000950103-19-008240 · dp108648_4-trotman.xml · nonDerivative · entry 2 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,847 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 18, 2019 Filed Jun 21, 2019 00:05 UTC | AMERICAN SHARED HOSPITAL SERVICES AMS · Entity 8010 | Exercise / conversionCommon Stock, No Par Value | 2,000 | $2.16 | $4,320.00 |
DisclosureSEC source: 0000950103-19-008240 · dp108648_4-trotman.xml · nonDerivative · entry 1 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,847 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2019 Filed May 17, 2019 20:31 UTC | AMERICAN SHARED HOSPITAL SERVICES AMS · Entity 8010 | SaleCommon Stock, No Par Value | 160,559 | $2.73 | $438,326.07 |
DisclosureSEC source: 0000950103-19-006531 · dp106908_4-trotman.xml · nonDerivative · entry 1 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,847 F1 · shares: The Reporting Person sold these shares in a private transaction. Read SEC document |
| June 14, 2018 Filed Jul 6, 2018 00:18 UTC | AMERICAN SHARED HOSPITAL SERVICES AMS · Entity 8010 | GrantStock Options (right to buy) · Derivative | 2,000 | $0.00 Strike: $2.68 | $0.00 |
DisclosureSEC source: 0001144204-18-037428 · tv496642_4.xml · derivative · entry 2 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2025-06-13 F3 · derivative.exercise_date: The reported stock option will vest in full upon the earlier of (I) the reporting person's completion of one year of service measured from June 14, 2018, or (II) such individual's continuation in Board service through the day immediately preceding the 2019 Annual Shareholders Meeting (the "Vesting Date"). Read SEC document |
| June 14, 2018 Filed Jul 6, 2018 00:18 UTC | AMERICAN SHARED HOSPITAL SERVICES AMS · Entity 8010 | GrantCommon Stock, No Par Value | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-037428 · tv496642_4.xml · nonDerivative · entry 1 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,406 F1 · shares: This represents an award of restricted stock units. Each unit will entitle the reporting person to one share of the issuer's common stock upon vesting. The units will vest in full upon the earlier of (I) the reporting person's completion of one year of service measured from June 14, 2018, or (II) such individual's continuation in Board service through the day immediately preceding the 2019 Annual Shareholders Meeting (the "Vesting Date"). F2 · balance_after: Includes 500 shares subject to the reported restricted stock unit award which will vest in full on the Vesting Date. Read SEC document |
| September 15, 2017 Filed Sep 15, 2017 12:08 UTC | WebMD Health Corp. WBMD · Entity 12671 | Disposition to issuerStock Option (right to buy) · Derivative | 13,200 | Not disclosed Strike: $49.57 | Not disclosed |
DisclosureSEC source: 0000947871-17-000723 · ss59051_4.xml · derivative · entry 9 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,200 shares Expires 2027-01-01 F2 · security: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD. F2 · price: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD. F2 · derivative.exercise_date: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD. Read SEC document |
| September 15, 2017 Filed Sep 15, 2017 12:08 UTC | WebMD Health Corp. WBMD · Entity 12671 | Disposition to issuerStock Option (right to buy) · Derivative | 13,200 | Not disclosed Strike: $48.30 | Not disclosed |
DisclosureSEC source: 0000947871-17-000723 · ss59051_4.xml · derivative · entry 8 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,200 shares Expires 2026-01-01 F2 · security: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD. F2 · price: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD. F2 · derivative.exercise_date: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD. Read SEC document |
| September 15, 2017 Filed Sep 15, 2017 12:08 UTC | WebMD Health Corp. WBMD · Entity 12671 | Disposition to issuerStock Option (right to buy) · Derivative | 13,200 | Not disclosed Strike: $39.55 | Not disclosed |
DisclosureSEC source: 0000947871-17-000723 · ss59051_4.xml · derivative · entry 7 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,200 shares Expires 2025-01-01 F2 · security: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD. F2 · price: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD. F2 · derivative.exercise_date: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD. Read SEC document |
| September 15, 2017 Filed Sep 15, 2017 12:08 UTC | WebMD Health Corp. WBMD · Entity 12671 | Disposition to issuerStock Option (right to buy) · Derivative | 13,200 | Not disclosed Strike: $39.50 | Not disclosed |
DisclosureSEC source: 0000947871-17-000723 · ss59051_4.xml · derivative · entry 6 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,200 shares Expires 2024-01-01 F2 · security: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD. F2 · price: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD. F2 · derivative.exercise_date: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD. Read SEC document |
| September 15, 2017 Filed Sep 15, 2017 12:08 UTC | WebMD Health Corp. WBMD · Entity 12671 | Disposition to issuerStock Option (right to buy) · Derivative | 6,600 | Not disclosed Strike: $14.34 | Not disclosed |
DisclosureSEC source: 0000947871-17-000723 · ss59051_4.xml · derivative · entry 5 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,600 shares Expires 2023-01-01 F2 · security: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD. F2 · price: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD. F2 · derivative.exercise_date: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD. Read SEC document |
| September 15, 2017 Filed Sep 15, 2017 12:08 UTC | WebMD Health Corp. WBMD · Entity 12671 | Disposition to issuerStock Option (right to buy) · Derivative | 13,200 | Not disclosed Strike: $37.55 | Not disclosed |
DisclosureSEC source: 0000947871-17-000723 · ss59051_4.xml · derivative · entry 4 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,200 shares Expires 2022-01-01 F2 · security: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD. F2 · price: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD. F2 · derivative.exercise_date: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD. Read SEC document |
| September 15, 2017 Filed Sep 15, 2017 12:08 UTC | WebMD Health Corp. WBMD · Entity 12671 | Disposition to issuerStock Option (right to buy) · Derivative | 13,200 | Not disclosed Strike: $38.49 | Not disclosed |
DisclosureSEC source: 0000947871-17-000723 · ss59051_4.xml · derivative · entry 3 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,200 shares Expires 2020-01-01 F2 · security: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD. F2 · price: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD. F2 · derivative.exercise_date: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD. Read SEC document |
| September 15, 2017 Filed Sep 15, 2017 12:08 UTC | WebMD Health Corp. WBMD · Entity 12671 | OtherCommon Stock | 935 | $66.50 | $62,177.50 |
DisclosureSEC source: 0000947871-17-000723 · ss59051_4.xml · nonDerivative · entry 2 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 0 F1 · shares: Sold in a tender offer made by Diagnosis Merger Sub, Inc., a Delaware Corporation ("Purchaser") and a wholly-owned subsidiary of MH Sub I, LLC, a Delaware limited liability company ("Parent"), to purchase all of the issued and outstanding shares of common stock of WebMD Health Corp., a Delaware corporation ("WebMD"), for $66.50 per share, pursuant to the terms of that certain Agreement and Plan of Merger, dated as of July 24, 2017, by and among WebMD, Purchaser, and Parent (the "Merger Agreement"). Read SEC document |
| September 15, 2017 Filed Sep 15, 2017 12:08 UTC | WebMD Health Corp. WBMD · Entity 12671 | OtherCommon Stock | 20,689 | $66.50 | $1,375,818.50 |
DisclosureSEC source: 0000947871-17-000723 · ss59051_4.xml · nonDerivative · entry 1 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: Sold in a tender offer made by Diagnosis Merger Sub, Inc., a Delaware Corporation ("Purchaser") and a wholly-owned subsidiary of MH Sub I, LLC, a Delaware limited liability company ("Parent"), to purchase all of the issued and outstanding shares of common stock of WebMD Health Corp., a Delaware corporation ("WebMD"), for $66.50 per share, pursuant to the terms of that certain Agreement and Plan of Merger, dated as of July 24, 2017, by and among WebMD, Purchaser, and Parent (the "Merger Agreement"). Read SEC document |
| June 27, 2017 Filed Jun 29, 2017 21:15 UTC | AMERICAN SHARED HOSPITAL SERVICES AMS · Entity 8010 | GrantStock Options (right to buy) · Derivative | 2,000 | $0.00 Strike: $3.90 | $0.00 |
DisclosureSEC source: 0001251638-17-000002 · primary_doc.xml · derivative · entry 2 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2024-06-26 F3 · derivative.exercise_date: The reported stock option will vest in full upon the earlier of (I) the reporting person's completion of one year of service measured from June 27, 2017, or (II) such individual's continuation in Board service through the day immediately preceding the 2018 Annual Shareholders Meeting (the "Vesting Date"). Read SEC document |
| June 27, 2017 Filed Jun 29, 2017 21:15 UTC | AMERICAN SHARED HOSPITAL SERVICES AMS · Entity 8010 | GrantCommon Stock, No Par Value | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001251638-17-000002 · primary_doc.xml · nonDerivative · entry 1 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,906 F1 · shares: This represents an award of restricted stock units. Each unit will entitle the reporting person to one share of the issuer's common stock upon vesting. The units will vest in full upon the earlier of (I) the reporting person's completion of one year of service measured from June 27, 2017, or (II) such individual's continuation in Board service through the day immediately preceding the 2018 Annual Shareholders Meeting (the "Vesting Date"). F2 · balance_after: Includes 500 shares subject to the reported restricted stock unit award which will vest in full on the Vesting Date. Read SEC document |
| March 27, 2017 Filed Mar 28, 2017 21:56 UTC | AMERICAN SHARED HOSPITAL SERVICES AMS · Entity 8010 | GiftCommon Stock | 87,705 | $4.30 | $377,131.50 |
DisclosureSEC source: 0001251638-17-000001 · primary_doc.xml · nonDerivative · entry 1 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,406 Read SEC document |
| January 01, 2017 Filed Jan 3, 2017 16:43 UTC | WebMD Health Corp. WBMD · Entity 12671 | GrantStock Option (right to buy) · Derivative | 13,200 | $0.00 Strike: $49.57 | $0.00 |
DisclosureSEC source: 0000947871-17-000009 · ss25387_4.xml · derivative · entry 1 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,200 Underlying: Common Stock · 13,200 shares Expires 2027-01-01 F1 · derivative.exercise_date: 25% of the shares underlying the option are scheduled to vest on each of the first, second, third and fourth anniversary of the date of the grant (fully vested on the 4th anniversary of the grant date). Read SEC document |
| December 07, 2016 Filed Dec 8, 2016 17:34 UTC | WebMD Health Corp. WBMD · Entity 12671 | SaleCommon Stock | 6,520 | $53.46 | $348,559.20 |
DisclosureSEC source: 0000947871-16-001755 · ss22811_4.xml · nonDerivative · entry 2 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,689 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.33 to $53.74 inclusive. The reporting person undertakes to provide to WebMD Health Corp., any security holder of WebMD Health Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.